Capitol Health Ltd
Capitol Health Limited provides diagnostic imaging modalities and related services to the healthcare market in Australia. It offers a range of diagnostic imaging services, including general x-ray, magnetic resonance imaging, ultrasound, mammography, Doppler, orthopantomogram, echocardiography, computed tomography, CT angiography, cone beam CT, nuclear medicine, bone densitometry, and fluoroscopy.… Read more
Capitol Health Ltd (CAJ) - Net Assets
Latest net assets as of June 2024: AU$110.66 Million AUD
Based on the latest financial reports, Capitol Health Ltd (CAJ) has net assets worth AU$110.66 Million AUD as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$319.48 Million) and total liabilities (AU$208.82 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$110.66 Million |
| % of Total Assets | 34.64% |
| Annual Growth Rate | 26.4% |
| 5-Year Change | -23.17% |
| 10-Year Change | 17.87% |
| Growth Volatility | 615.21 |
Capitol Health Ltd - Net Assets Trend (2006–2024)
This chart illustrates how Capitol Health Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Capitol Health Ltd (2006–2024)
The table below shows the annual net assets of Capitol Health Ltd from 2006 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | AU$110.66 Million | -19.86% |
| 2023-06-30 | AU$138.08 Million | -10.36% |
| 2022-06-30 | AU$154.04 Million | +5.49% |
| 2021-06-30 | AU$146.03 Million | +1.38% |
| 2020-06-30 | AU$144.04 Million | +29.52% |
| 2019-06-30 | AU$111.21 Million | +9.17% |
| 2018-06-30 | AU$101.86 Million | -14.42% |
| 2017-06-30 | AU$119.03 Million | +40.63% |
| 2016-06-30 | AU$84.64 Million | -9.85% |
| 2015-06-30 | AU$93.88 Million | +142.82% |
| 2014-06-30 | AU$38.66 Million | +13.37% |
| 2013-06-30 | AU$34.11 Million | +39.40% |
| 2012-06-30 | AU$24.46 Million | +21.04% |
| 2011-06-30 | AU$20.21 Million | +4.96% |
| 2010-06-30 | AU$19.26 Million | +9.01% |
| 2009-06-30 | AU$17.66 Million | -5.45% |
| 2008-06-30 | AU$18.68 Million | +2692.02% |
| 2007-06-30 | AU$669.12K | -59.00% |
| 2006-06-30 | AU$1.63 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Capitol Health Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5500500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$161.14 Million | 145.29% |
| Other Comprehensive Income | AU$4.78 Million | 4.31% |
| Total Equity | AU$110.91 Million | 100.00% |
Capitol Health Ltd Competitors by Market Cap
The table below lists competitors of Capitol Health Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sebang Global Battery Co Ltd
KO:004490
|
$222.68 Million |
|
Zhejiang Risun Intelligent Technology Co. Ltd. A
SHG:688215
|
$222.69 Million |
|
Yuanli Chemical Group Co Ltd
SHG:603217
|
$222.73 Million |
|
VT GMP Co.Ltd
KQ:018290
|
$222.74 Million |
|
Harbin Air Conditioning Co Ltd
SHG:600202
|
$222.65 Million |
|
Tianyu Ecology & Landscape Co
SHG:603717
|
$222.65 Million |
|
Mekonomen AB
ST:MEKO
|
$222.64 Million |
|
Rechi Precision Co Ltd
TW:4532
|
$222.59 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Capitol Health Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 137,093,000 to 110,910,000, a change of -26,183,000 (-19.1%).
- Net loss of 14,853,000 reduced equity.
- Dividend payments of 10,658,000 reduced retained earnings.
- New share issuances of 518,000 increased equity.
- Other comprehensive income increased equity by 2,071,000.
- Other factors decreased equity by 3,261,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-14.85 Million | -13.39% |
| Dividends Paid | AU$10.66 Million | -9.61% |
| Share Issuances | AU$518.00K | +0.47% |
| Other Comprehensive Income | AU$2.07 Million | +1.87% |
| Other Changes | AU$-3.26 Million | -2.94% |
| Total Change | AU$- | -19.10% |
Book Value vs Market Value Analysis
This analysis compares Capitol Health Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.69x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 32.47x to 3.69x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-06-30 | AU$0.01 | AU$0.39 | x |
| 2008-06-30 | AU$0.08 | AU$0.39 | x |
| 2009-06-30 | AU$0.06 | AU$0.39 | x |
| 2010-06-30 | AU$0.06 | AU$0.39 | x |
| 2011-06-30 | AU$0.06 | AU$0.39 | x |
| 2012-06-30 | AU$0.07 | AU$0.39 | x |
| 2013-06-30 | AU$0.09 | AU$0.39 | x |
| 2014-06-30 | AU$0.09 | AU$0.39 | x |
| 2015-06-30 | AU$0.20 | AU$0.39 | x |
| 2016-06-30 | AU$0.16 | AU$0.39 | x |
| 2017-06-30 | AU$0.20 | AU$0.39 | x |
| 2018-06-30 | AU$0.13 | AU$0.39 | x |
| 2019-06-30 | AU$0.14 | AU$0.39 | x |
| 2020-06-30 | AU$0.17 | AU$0.39 | x |
| 2021-06-30 | AU$0.14 | AU$0.39 | x |
| 2022-06-30 | AU$0.14 | AU$0.39 | x |
| 2023-06-30 | AU$0.13 | AU$0.39 | x |
| 2024-06-30 | AU$0.10 | AU$0.39 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Capitol Health Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -13.39%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -6.33%
- • Asset Turnover: 0.73x
- • Equity Multiplier: 2.88x
- Recent ROE (-13.39%) is below the historical average (-4.83%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | -144.42% | -61.85% | 0.77x | 3.05x | AU$-1.03 Million |
| 2008 | 1.15% | 1.60% | 0.45x | 1.60x | AU$-1.65 Million |
| 2009 | -5.76% | -3.60% | 1.04x | 1.55x | AU$-2.78 Million |
| 2010 | 3.66% | 1.99% | 1.10x | 1.67x | AU$-1.22 Million |
| 2011 | 4.76% | 2.11% | 1.35x | 1.67x | AU$-1.06 Million |
| 2012 | 8.72% | 4.14% | 1.39x | 1.51x | AU$-312.27K |
| 2013 | 10.64% | 5.82% | 1.10x | 1.67x | AU$216.83K |
| 2014 | 18.71% | 8.05% | 1.44x | 1.61x | AU$3.37 Million |
| 2015 | 4.12% | 3.51% | 0.57x | 2.05x | AU$-5.52 Million |
| 2016 | 1.99% | 1.61% | 0.49x | 2.51x | AU$-6.78 Million |
| 2017 | 1.47% | 1.62% | 0.53x | 1.72x | AU$-10.16 Million |
| 2018 | -10.85% | -9.29% | 0.92x | 1.27x | AU$-21.24 Million |
| 2019 | 24.76% | 18.45% | 0.82x | 1.64x | AU$16.41 Million |
| 2020 | 0.60% | 0.56% | 0.59x | 1.82x | AU$-13.52 Million |
| 2021 | 8.18% | 6.70% | 0.64x | 1.92x | AU$-2.65 Million |
| 2022 | 7.01% | 5.83% | 0.69x | 1.74x | AU$-4.57 Million |
| 2023 | -8.31% | -5.44% | 0.66x | 2.32x | AU$-25.10 Million |
| 2024 | -13.39% | -6.33% | 0.73x | 2.88x | AU$-25.94 Million |
Industry Comparison
This section compares Capitol Health Ltd's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $161,246,063
- Average return on equity (ROE) among peers: -31.47%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Capitol Health Ltd (CAJ) | AU$110.66 Million | -144.42% | 1.89x | $222.66 Million |
| Australian Clinical Labs Ltd (ACL) | $68.99 Million | 59.80% | 4.31x | $217.50 Million |
| Bcal Diagnostics Ltd (BDX) | $6.22 Million | -116.40% | 0.59x | $10.33 Million |
| Cryosite Ltd (CTE) | $1.45 Million | 126.98% | 12.60x | $5.03 Million |
| Genetic Signatures Ltd (GSS) | $16.18 Million | -10.68% | 0.02x | $8.20 Million |
| Healius Ltd (HLS) | $1.04 Billion | -62.05% | 1.87x | $208.81 Million |
| Inoviq Ltd (IIQ) | $2.83 Million | -115.42% | 0.16x | $23.33 Million |
| Microba Life Sciences Ltd (MAP) | $32.49 Million | -45.98% | 0.46x | $10.42 Million |
| Monash Ivf Group Ltd (MVF) | $268.44 Million | 9.37% | 0.33x | $116.82 Million |
| Pacific Edge Ltd (PEB) | $13.91 Million | -128.81% | 0.19x | $89.67 Million |